The Coretec Group Releases Shareholder Letter Highlighting the CHS Commercialization Timeline, Evonik Partnership and Customer Updates

Author's Avatar
Nov 02, 2020
Article's Main Image

ANN ARBOR, MI / ACCESSWIRE / November 2, 2020 / The Coretec Group, Inc., (OTCQB:CRTG) ("Coretec"), a company developing a portfolio of silicon-based materials utilizing Cyclohexasilane ("CHS") to pursue commercial development of products in energy-focused verticals today issued a letter from CEO Michael Kraft to its shareholders: